Works matching IS 03618609 AND DT 2019 AND VI 94 AND IP 7


Results: 21
    1
    2
    3

    Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. E188, doi. 10.1002/ajh.25490
    By:
    • Strati, Paolo;
    • Garcia‐Manero, Guillermo;
    • Zhao, Chong;
    • Kadia, Tapan;
    • Borthakur, Gautam;
    • Konopleva, Marina;
    • Daver, Naval;
    • DiNardo, Courtney D.;
    • Short, Nicholas J.;
    • Yilmaz, Musa;
    • Naqvi, Kiran;
    • Alvarado, Yesid;
    • Pierce, Sherry A.;
    • Cortes, Jorge;
    • Bueso‐Ramos, Carlos;
    • Kantarjian, Hagop;
    • Ravandi, Farhad
    Publication type:
    Article
    4

    Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. E185, doi. 10.1002/ajh.25489
    By:
    • Rumi, Elisa;
    • Zibellini, Silvia;
    • Boveri, Emanuela;
    • Cavalloni, Chiara;
    • Riboni, Roberta;
    • Casetti, Ilaria Carola;
    • Ciboddo, Michele;
    • Trotti, Chiara;
    • Favaron, Cristina;
    • Pietra, Daniela;
    • Candido, Chiara;
    • Ferretti, Virginia Valeria;
    • Cazzola, Mario;
    • Arcaini, Luca
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. 767, doi. 10.1002/ajh.25488
    By:
    • Coston, Tucker;
    • Pophali, Prateek;
    • Vallapureddy, Rangit;
    • Lasho, Terra L.;
    • Finke, Christy M.;
    • Ketterling, Rhett P.;
    • Carr, Ryan;
    • Binder, Moritz;
    • Mangaonkar, Abhishek A.;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Litzow, Mark;
    • Zblewski, Darci;
    • Pardanani, Animesh;
    • Tefferi, Ayalew;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    11

    DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. 757, doi. 10.1002/ajh.25486
    By:
    • Quesada, Andrés E.;
    • Routbort, Mark J.;
    • DiNardo, Courtney D.;
    • Bueso‐Ramos, Carlos E.;
    • Kanagal‐Shamanna, Rashmi;
    • Khoury, Joseph D.;
    • Thakral, Beenu;
    • Zuo, Zhuang;
    • Yin, C. Cameron;
    • Loghavi, Sanam;
    • Ok, Chi Y.;
    • Wang, Sa A.;
    • Tang, Zhenya;
    • Bannon, Sarah A.;
    • Benton, Christopher B.;
    • Garcia‐Manero, Guillermo;
    • Kantarjian, Hagop;
    • Luthra, Rajyalakshmi;
    • Medeiros, L. Jeffrey;
    • Patel, Keyur P.
    Publication type:
    Article
    12
    13
    14

    Immune neutropenia mediated by micafungin.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. 830, doi. 10.1002/ajh.25483
    By:
    • Ameri, Amir H.;
    • Curtis, Brian R.;
    • Sykes, David B.
    Publication type:
    Article
    15

    The D‐dimer assay.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. 833, doi. 10.1002/ajh.25482
    By:
    • Johnson, Eric D.;
    • Schell, John C.;
    • Rodgers, George M.
    Publication type:
    Article
    16

    Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. 751, doi. 10.1002/ajh.25481
    By:
    • Tschautscher, Marcella A.;
    • Jevremovic, Dragan;
    • Rajkumar, Vincent;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Gertz, Morie A.;
    • Buadi, Francis K.;
    • Dingli, David;
    • Hwa, Yi L.;
    • Fonder, Amie L.;
    • Hobbs, Miriam A.;
    • Hayman, Suzanne R.;
    • Zeldenrust, Steven R.;
    • Lust, John A.;
    • Russell, Stephen J.;
    • Leung, Nelson;
    • Kapoor, Prashant;
    • Go, Ronald S.;
    • Lin, Yi;
    • Gonsalves, Wilson I.
    Publication type:
    Article
    17

    Second‐line treatments in children with immune thrombocytopenia: Effect on platelet count and patient‐centered outcomes.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. 741, doi. 10.1002/ajh.25479
    By:
    • Grace, Rachael F.;
    • Shimano, Kristin A.;
    • Bhat, Rukhmi;
    • Neunert, Cindy;
    • Bussel, James B.;
    • Klaassen, Robert J.;
    • Lambert, Michele P.;
    • Rothman, Jennifer A.;
    • Breakey, Vicky R.;
    • Hege, Kerry;
    • Bennett, Carolyn M.;
    • Rose, Melissa J.;
    • Haley, Kristina M.;
    • Buchanan, George R.;
    • Geddis, Amy;
    • Lorenzana, Adonis;
    • Jeng, Michael;
    • Pastore, Yves D.;
    • Crary, Shelley E.;
    • Neier, Michelle
    Publication type:
    Article
    18

    Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. E183, doi. 10.1002/ajh.25480
    By:
    • Quinquenel, Anne;
    • Godet, Sophie;
    • Dartigeas, Caroline;
    • Ysebaert, Loïc;
    • Dupuis, Jehan;
    • Ohanyan, Haykanush;
    • Collignon, Aude;
    • Gilardin, Laurent;
    • Lepretre, Stéphane;
    • Dilhuydy, Marie‐Sarah;
    • Vignon, Marguerite;
    • Guibert, Sophie;
    • Dmytruk, Natalia;
    • Durot, Eric;
    • Ghez, David;
    • Roos Weil, Damien;
    • Béné, Marie‐Christine;
    • Toussaint, Elise;
    • Merabet, Fatiha;
    • Lévy, Vincent
    Publication type:
    Article
    19
    20

    Concomitant classic Hodgkin lymphoma and schistosomiasis.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 7, p. 840, doi. 10.1002/ajh.25316
    By:
    • Wong, Waihay J.;
    • Ruhangaza, Deogratias;
    • Manirakiza, Alexis;
    • Omondi, Jack;
    • Mugabe, Marcellin C.;
    • Isabelle, Izimukwiye;
    • Morgan, Elizabeth A.;
    • Aster, Jon C.
    Publication type:
    Article
    21